Protara Therapeutics, Inc.

NasdaqGM:TARA Stock Report

Mkt Cap: US$33.4m

Protara Therapeutics Future Growth

How is Protara Therapeutics forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


37.5%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

NasdaqGM:TARA - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202557-16-40N/A4
12/31/20249-47-56N/A4
12/31/2023N/A-52-50N/A4
9/30/2022N/A-37-28-28N/A
6/30/2022N/A-40-29-29N/A
3/31/2022N/A-45-34-34N/A
12/31/2021N/A-47-35-35N/A
9/30/2021N/A-46-35-34N/A
6/30/2021N/A-43-33-32N/A
3/31/2021N/A-37-29-28N/A
12/31/2020N/A-34-24-23N/A
9/30/2020N/A-28-18-18N/A
6/30/2020N/A-22-16-15N/A
3/31/2020N/A-16-11-11N/A
12/31/2019N/A-8-5-5N/A
9/30/2019N/A-7-5-5N/A
12/31/2018N/A-4-3-3N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: TARA is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: TARA is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: TARA is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: TARA is forecast to have no revenue next year.

High Growth Revenue: TARA is forecast to have no revenue next year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if TARA's Return on Equity is forecast to be high in 3 years time


Discover growth companies